cilazapril, anhydrous has been researched along with Cardiomegaly in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartel, S; Hempel, P; Hoch, B; Karczewski, P | 1 |
| Nico, B; Pirrelli, A; Ricci, S; Roncali, L; Seccia, TM; Vulpis, V | 1 |
| Sesin, J; Tamargo, J | 1 |
| Li, JS; Schiffrin, EL; Sventek, P | 1 |
| Abe, K; Isoyama, S; Nitta, Y; Tajima, M | 1 |
| Asahi, T; Oshiro, Y; Shimabukuro, M; Takasu, N; Yoshida, H | 1 |
| Busch, C; Dietz, R; Förderer, T; Haberbosch, W; Osterziel, KJ | 1 |
| De Simone, R; Dietz, R; Haberbosch, W; Kübler, W; Tillmanns, H; Waas, W | 1 |
| Clozel, JP; Hess, P; Sprecher, U; Véniant, M | 1 |
| Clozel, JP; Hefti, F | 2 |
| Clozel, JP; Hefti, F; Kuhn, H | 1 |
| Burkart, F; Kiowski, W | 1 |
13 other study(ies) available for cilazapril, anhydrous and Cardiomegaly
| Article | Year |
|---|---|
Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cilazapril; Genetic Predisposition to Disease; In Vitro Techniques; Isoenzymes; Male; Myocardium; Organ Size; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Transcription, Genetic | 2002 |
Left ventricular hypertrophy in spontaneously hypertensive rat: effects of ACE-inhibition on myocardiocyte ultrastructure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Cilazapril; Heart Rate; Hypertension; Hypertrophy; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Ventricular Function, Left | 1995 |
[Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Cilazapril; Endothelium, Vascular; Humans; Hypertension; Rats; Renin-Angiotensin System; Vasodilation | 1996 |
Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Body Weight; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Desoxycorticosterone; Endothelin-1; Hypertension; NG-Nitroarginine Methyl Ester; Nifedipine; Organ Size; Rats; Rats, Sprague-Dawley; Renin | 1996 |
Attenuation of heat shock protein expression by coronary occlusion in hypertrophied hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Carrier Proteins; Cilazapril; Coronary Disease; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Male; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 1997 |
Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Size; Cilazapril; Coronary Circulation; Hemodynamics; Hyperthyroidism; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Myocardium; Organ Size; Oxygen Consumption; Propranolol; Rats; Rats, Sprague-Dawley; Triiodothyronine | 2001 |
[Reparative effects of ACE inhibitors on the heart].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitors; Cardiac Volume; Cardiomegaly; Cilazapril; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Pyridazines | 1992 |
Improvement of diastolic filling in hypertensive patients treated with cilazapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomegaly; Cilazapril; Echocardiography, Doppler; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pyridazines; Ventricular Function | 1991 |
Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Cilazapril; Coronary Circulation; Dose-Response Relationship, Drug; Hydralazine; Hypertension; Male; Perfusion; Pyridazines; Rats; Rats, Inbred SHR | 1991 |
Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Cilazapril; Hemodynamics; Male; Pyridazines; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance; Vasodilation | 1987 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary Circulation; Dipyridamole; Heart; Hypertension; Male; Organ Size; Pyridazines; Rats; Rats, Inbred SHR; Regional Blood Flow | 1988 |
Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cilazapril; Coronary Circulation; Coronary Vessels; Hypertension; Male; Microcirculation; Pyridazines; Rats; Rats, Inbred SHR; Time Factors | 1989 |
Effects of vasodilators on the coronary circulation in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Coronary Circulation; Heart Failure; Humans; Hydralazine; Nitroglycerin; Prazosin; Pyridazines; Vasodilator Agents | 1988 |